Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $37.10 USD
Change Today -0.45 / -1.20%
Volume 49.6K
LDR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

landauer inc (LDR) Snapshot

Open
$37.77
Previous Close
$37.55
Day High
$38.49
Day Low
$36.77
52 Week High
08/24/15 - $42.90
52 Week Low
01/30/15 - $27.87
Market Cap
355.4M
Average Volume 10 Days
72.4K
EPS TTM
$1.68
Shares Outstanding
9.6M
EX-Date
09/9/15
P/E TM
22.1x
Dividend
$1.10
Dividend Yield
4.45%
Current Stock Chart for LANDAUER INC (LDR)

Related News

No related news articles were found.

landauer inc (LDR) Related Businessweek News

No Related Businessweek News Found

landauer inc (LDR) Details

Landauer, Inc., together with its subsidiaries, provides technical and analytical services, outsourced medical physics services, and radiology related medical products Worldwide. The company operates in three segments: Radiation Measurement, Medical Physics, and Medical Products. The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure; manufactures various radiation detection monitors; and distributes and collects monitors to and from customers, as well as analyzes and reports exposure findings. It also sells dosimetry detectors and reading equipment. This segment provides its services primarily to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities, and other industries. The Medical Physics segment offers therapeutic and imaging physics services comprising clinical physics support, equipment commissioning, accreditation support, and imaging equipment testing to hospitals, radiation therapy centers, and imaging centers. The Medical Products segment provides medical consumable accessories that are used in radiology, radiation therapy, and image guided surgery procedures. It products include consumables used with MRI, CT, and mammography technologies; and passive reflective markers used during image guided surgery procedures. The company was founded in 1954 and is based in Glenwood, Illinois.

600 Employees
Last Reported Date: 02/3/15
Founded in 1954

landauer inc (LDR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $59.8K
Senior Vice President of Strategic Marketing ...
Total Annual Compensation: $247.2K
President of Radiation Measurement
Total Annual Compensation: $350.0K
Advisor
Total Annual Compensation: $252.9K
Compensation as of Fiscal Year 2014.

landauer inc (LDR) Key Developments

Landauer, Inc. Announces Management Changes, Effective from October 1, 2015

Landauer Inc. announced that its board of directors has elected Michael P. Kaminski to succeed Michael T. Leatherman as President and Chief Executive Officer of the company, effective October 1, 2015. Mr. Kaminski has also been appointed to the company's board of directors, effective the same date. Mr. Kaminski currently serves as President of the company's Radiation Measurement business. In addition, the board of directors appointed Mr. Leatherman to the role of Executive Chairman of the board of directors and announced that Robert Cronin, the company's current Chairman, will become the board's Lead Independent Director, both effective October 1, 2015. Mr. Kaminski joined the company in April 2013 as President of the Radiation Measurement Division. Prior to joining the company, Mr. Kaminski was the President and CEO of Stereotaxis.

Landauer, Inc. Declares Regular Cash Dividend, Payable on October 2, 2015

Landauer Inc. announced that its board of directors declared on August 25, 2015, a regular quarterly cash dividend of $0.275 per share. The dividend will be paid on October 2, 2015, to shareholders of record on September 11, 2015.

Landauer Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015; Revises Earnings Guidance for the Fiscal Year 2015

Landauer Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended June 30, 2015. For the quarter, the company's revenues were $35.5 million, a 1.1% decrease compared to revenues of $35.9 million for the third fiscal quarter of 2014. The decrease in Revenue was primarily due to the unfavorable impact of changes in foreign currency exchange rates of $1.5 million, partially offset by an increase in domestic revenues of $0.3 million. Operating income for the quarter was $5.1 million, compared with an operating loss of $59.6 million for the third fiscal quarter of 2014. The increase in operating income was driven by the $62.2 million goodwill and other intangible assets impairment charge, and $1.6 million in reorganization expenses recorded during the third fiscal quarter of 2014 that were not present in the third fiscal quarter of 2015. Adjusted operating income was $5.1 million compared with $4.1 million a year ago. Adjusted operating income increased $1.0 million due to its lean initiatives and continued focus on higher margin, recurring revenues. Income before taxes was $4.6 million compared with loss before taxes of $60.3 million a year ago. Net income attributed to the company was $4.1 million or $0.42 per diluted share compared with net loss of $36.3 million or $3.83 per diluted share a year ago. Adjusted EBITDA was $9.2 million compared with $8.5 million a year ago. EBITDA was $8.7 million compared with loss of $55.9 million a year ago. Adjusted net income was $4.5 million compared with $2.2 million a year ago. For the nine months, the company's revenues were $111.2 million, a 1.7% decrease compared to revenues of $113.1 million for the first nine months of fiscal 2014. Operating income for the period was $16.9 million, compared to an operating loss of $47.3 million for the first nine months of fiscal 2014. The increase in operating income was due to the goodwill and other intangible assets impairment charge recorded in the prior year that was not present in the first nine months of fiscal 2015. Income before taxes was $15.6 million compared with loss before taxes of $47.9 million a year ago. Net income attributed to the company was $11.98 million or $1.25 per diluted share compared with net loss of $28.0 million or $2.96 per diluted share a year ago. Net cash provided by operating activities was $21.7 million compared with $26.6 million a year ago. Adjusted EBITDA was $28.6 million compared with $30.6 million a year ago. EBITDA was $27.2 million compared with loss of $34.5 million a year ago. Adjusted operating income was $16.9 million compared with $16.6 million a year ago. Adjusted net income was $13.1 million compared with $10.96 million a year ago. Capital expenditures were $6.2 million compared with $3.1 million a year ago. For the fiscal year 2015, the company expects revenue in the range of $150 million - $153 million compared to previous guidance of $153 million - $163 million, adjusted net income in the range of $17 million - $19 million compared to previous guidance of $16 million - $19 million, adjusted EBITDA in the range of $38 million - $41 million compared to previous guidance of $41 million - $46 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LDR:US $37.10 USD -0.45

LDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $0.59 USD +0.02
Globus Medical Inc $23.83 USD -0.09
NuVasive Inc $51.69 USD -0.46
Orthofix International NV $37.28 USD +0.05
View Industry Companies
 

Industry Analysis

LDR

Industry Average

Valuation LDR Industry Range
Price/Earnings 24.4x
Price/Sales 2.3x
Price/Book 31.4x
Price/Cash Flow 24.3x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANDAUER INC, please visit www.landauerinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.